The global genomics market held US$ 18,964.2 Mn in 2020 and expected to grow at compound annual growth rate (CAGR) of 10.4% during the forecast period from 2025 to 2033. The exploration of genomics has surpassed in the last three decades to massive advancements in the technology that allowed the researchers to sequence larger pieces of genome.
The currently available techniques applied in surface disinfection are consistently improving to adapt to any environment. Conventional disinfection activities mainly aim to supplement healthcare facilities and improve healthcare system efficiency. As the overall emphasis on disinfection and maintaining sterile environment is advancing, the use of surfaces with inherent antimicrobial properties is being considered as a potential alternative to disinfection. However, the possible high cost of these items and distant availability have made the use of disinfectants imperative.
The travel vaccines market is set to reach US$ 9,068.9 Mn by 2033 from US$ 4730.3 Mn in 2021 showcasing steady growth at a compounded annual growth rate (CAGR) of 7.5% during the forecast period from 2025 to 2033. As per the research findings of World Tourism Organization (WTO) the number of international arrivals throughout the globe is expected to reach 1.6 billion by 2020.
The Contract Development and Manufacturing Organization (CDMO) industry had begun decades ago as a niche business by offering specialty services and manufacturing capacities to pharmaceutical companies. The advent of CDMOs was mainly attributed to the failures of pharmaceutical companies due to challenged competencies and financial constraints.
The global medical electrodes market accounted for a value of US$ 1,217.3 Mn in 2017, and expected to attain US$ 2,406.9 Mn by 2026. Factors characterizing the growth of this market are globally growing elder population base, along with increasing adoption of medical electrodes for the diagnosis and treatment of various conditions, technological advances in medical electrodes, and rising preference for minimally invasive procedures.
Global industrial heat exchangers market was valued at US$ 13,978.5 Mn in 2020 and set to grow at a CAGR of 7.6% throughout the forecast period from 2021 to 2029. Growing industrialization among developing countries noted as one of the prominent factors driving industrial heat exchangers market worldwide. Heat exchanger serves broad range of industry applications. Numerous industries including chemical, oil & gas, food & beverage, power generation along with HVAC and pulp & paper industry are increasingly adopting heat exchangers as a component of heating as well as cooling systems.
The human microbiome market is set to reach US$ 1,990.5 Mn by 2029 from US$ 840.1 Mn in 2020 at a compound annual growth rate (CAGR) of 10.1% during the forecast period from 2021 to 2029. According to the research findings of World Health Organization (WHO), the burden associated with non-communicable diseases is set increase to 57% by 2020. The mortality rate related to chronic diseases will be more pronounced in the developing regions in comparison to the developed regions.
Dietary Fibers market is projected to reach US$ 11.35 Bn by 2029 with 11.1% CAGR during the forecast period from 2021 to 2029. In 2020, North America held the largest value and volume share in the global dietary fibers market and Asia Pacific is projected to be the fastest growing region between 2021 and 2029.
Organic acids market is projected to grow at 6.2% CAGR during the forecast period from 2021 to 2029. In 2020, Asia Pacific held the largest value and volume share in the global organic acids market and is projected to be the fastest-growing region between 2019 and 2029.
Body oils market projected to grow at a CAGR of 4.2% during the forecast period from 2021 to 2029. In 2020, Asia Pacific held the leading market share in terms of revenue. Body oils function as an emollient and an occlusive thus preventing cell cohesion and transepidermal water loss. It has essential ingredients such as vitamins, fatty acids, antioxidants, and polyphenols among others.
The drugs by therapeutic area include therapy for oncology, cardiovascular, central nervous system, infectious diseases, respiratory, and others. The therapeutic area represents the specific area of medicine where the drug is intended to be used, based on its mechanism of action and intended clinical use. One of the primary drivers of the drugs by therapeutic area market is the increasing prevalence of diseases worldwide. Chronic diseases such as cancer, cardiovascular diseases, and neurological disorders are a significant burden on healthcare systems globally. There is an urgent need for new and effective therapies to treat these diseases, which has led to the growth of the drugs in the therapeutic area market.
The revenues generated by the drugs in the therapeutic area market have been consistently high over the years. The global pharmaceutical market is expected to reach USD 1.5 trillion by 2023, with oncology being the leading therapeutic area. The increasing demand for new therapies, coupled with advancements in technology and an increasing focus on personalized medicine, is expected to drive the growth of the market in the coming years. One of the emerging trends in the drugs by therapeutic area market is the increasing use of precision medicine. Precision medicine involves tailoring medical treatments to individual patients based on their unique genetic and molecular profiles. The development of precision medicine requires the use of advanced diagnostic tools and drug discovery technologies, which have contributed to the growth of drugs in the therapeutic area market.
Another trend in the drugs by therapeutic area market is the increasing focus on biologics. Biologics are drugs that are produced from living cells and are used to treat a wide range of diseases, including cancer and autoimmune disorders. Biologics are more complex than traditional small-molecule drugs, and their development requires specialized manufacturing processes and clinical trial design. The increasing demand for biologics has contributed to the growth of the drugs by therapeutic area market. The increasing focus on rare diseases is also driving the growth of the drugs by therapeutic area market. Rare diseases are defined as diseases that affect fewer than 200,000 people in the United States. Although each rare disease affects a small number of people, there are over 7,000 rare diseases, which together affect millions of people worldwide. There is an urgent need for new therapies to treat rare diseases, which has led to the growth of drugs in the therapeutic area market.
The increasing use of combination therapies is driving the growth of the drugs by therapeutic area market. Combination therapies involve the use of two or more drugs to treat a disease. Combination therapies can improve patient outcomes by targeting multiple pathways involved in the disease process. The development of combination therapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the drugs by therapeutic area market. The increasing prevalence of diseases worldwide, advancements in technology, and the emerging trends in precision medicine, biologics, rare diseases, and combination therapies are expected to drive the growth of the drugs by therapeutic area market.
